Tekrarlayan Üriner Sistem Enfeksiyonları ve Komplike Sistitler

Bonkat G, Bartoletti R, Bruyère F, et al. (2020). EAU Guidelines on Urological Infections içinde (s. 41-44), EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam the Netherlands 2020. ISBN 978-94-92671-07-3.

Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am 2014;28:1–13

Jackson SL, Boyko IJ, Scholes D, et al. Predictors of urinary tract infection after menopause. Am J Med 2004;117:903

American College of Obstetricians and Gynecologists. Treatment of urinary tract infection in non pregnant women. ACOG Practice Bulletin No. 91, March 2008. Obstet Gynecol 2008;11:785–94

Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrobial Agents 2001;17:259–268

Kraft JK, Stamey TA. The natural history of symptomatic recurrentbacteruria in women. Medicine 1977;56:55–60.10.

Gupta K, Stamm WE. Pathogenesis and management of recurrent urinarytract infecitons in women. World J Urol 1999;17:415–20.

Foxman B, Gillespie B, Koopman J, et al. Risk fctors for second urinary tract infection among college women. Am J Epidemiol 2000;151:1194–205

Eriksson I, Gustafson Y, Fagerstrom L, et al. Do urinary tractinfections affect morale among very old women? Health Qual Life Outcomes 2010;8:73–8.

Abrahamian FM, Krishnadasan A, Mower WR, et al. The association of antimicrobial resistance with cure andquality of life among women with acute uncomplicated cystitis.Infection 2011;39:507–14.

Bent S, Nallamothu BK, Simel DL, et al. Does this woman have an acute urinary tract infection? JAMA 2002;287:2701–10.

Gupta K, Hooton TM, Roberts PL, et al. Patient-initiated treatment of recurrent urinary tract infection in women. Ann Intern Med 2001;135:9–16.

Gopal M, Northington G, Arya L. Clinical symptoms predictive of recurrent urinary tract infection. Am J Obstet Gynecol 2007;197:74.e1–4.

Fowler Jr. JE. Urinary tract infections in women. Urol Clin North Am 1986;13:673–83.

Stamey TA. Recurrent urinary tract infections in female patients:an overview of management and treatment. Rev Infect Dis 1987;9(Suppl 2):S195–210

Bent S, Nallamothu BK, Simel DL, et al. Does this womanhave an acute urinary tract infection? JAMA 2002;287:2701–10.

Mulvey MA, Schilling JD, Jultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 2001;69:4572–9.

Rosen DA, Hooten TM, Stamm WE, et al. Detection of intracellular bacterial communities in human urinary tract infection. PLOS Med 2007;4:e329.

Fihn SD. Acute uncomplicated urinary tract infection in women. N Engl J Med 2003; 349:259-266.

Johnson JR, Clabots C. Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis. Clin Infect Dis 2006;43:e101–8.

Gupta K, Stapleton AE, Hooton TM, et al. Inverse association of H202-producing Lactobacilli and vaginal E. colicolonization in women with recurrent urinary tract infection. J Infect Dis 1998; 178:446–50.

Schaeffer AJ. Recurrent urinary tract infections in women. Pathogenesis and management. Postgrad Med 1987; 81:51–8.

Rosen DA, Hooton TM, Stamm WE, et al. Detection of intracellular bacterial communities in human urinarytract infection. PLoS Med 2007; 4:1949–58

Lundstedt AC, Leijonhufvud I, Ragnarsdottir B, et al. Inherited susceptibility to acute pyelonephritis:a family study of urinary tract infection. J Infect Dis 2007; 195:1227–34

Scholes D, Hooton TM, Roberts PL, et al. Risk factors for recurrent urinary tract infection in young women. J InfectDis 2000; 182:1177–82.

Minardi D, Parri G, d’Anzeo G, et al. Perineal ultrasound evaluation of dysfunctional voiding in women with recurrent urinary tract infections. J Urol 2008; 179:947–51

R.M. Klevens, J.R. Edwards, C.L. Richards Jr., et al.Estimating health care-associated infections and deaths in U.S. hospitals, 2002 Public Health Rep, 122 (2007), pp. 160-166

G. Reid, M. Habash, D. Vachon, J., et al. Oral fluoroquinolone therapy results in drug adsorption on ureteral stents and prevention of biofilm formationInt J Antimicrob Agents, 17 (2001), pp. 317-319

M. Shigeta, H. Komatsuzawa, M. Sugai, H., et al. Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents Chemotherapy, 43 (1997), pp. 137-141

P. Tenke, B. Kovacs, T.E. Bjerklund Johansen, et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections Int J Antimicrob Agents, 31 (Suppl 1) (2008), pp. S68-S78

D.J. De Ridder, K. Everaert, L.G. Fernandez, et al. Intermittent catheterisation with hydrophilic-coated catheters (SpeediCath) reduces the risk of clinical urinary tract infection in spinal cord injured patients: a prospective randomised parallel comparative trial Eur Urol, 48 (2005), pp. 991-995

.L. Li, W. Ye, H. Ruan, et al. LiImpact of hydrophilic catheters on urinary tract infections in people with spinal cord injury: systematic review and meta-analysis of randomized controlled trials Arch Phys Med Rehabil, 94 (2013), pp. 782-787

Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010 Mar 1. 50(5):625-63.

Vahlensieck W. Therapy strategies in recurrent urinary tract infections [in German]. Nieren- und Hochdruckkrkh 2015; 44:299–306

O’Grady F, Cattell WR. Kinetics of urinary tract infection. II. The bladder. Br J Urol 1966; 38:156

Li Y, Qu H, Xiang Q, et al. Overview on the recent study of antimicrobial peptides: origins, functions, relative mechanisms andapplication. Peptides 2012; 37:207–15.

Hertting O, Holm A, Luthje P, et al. Vitamin D induction of thehuman antimicrobial Peptide cathelicidin in the urinary bladder. PLoS One 2010; 5(12):e15580.

Schmidt DR, Sobota AE. An examination of the antiadherence activityof cranberry juice on urinary and non-urinary bacterial isolates. Microbios 1988; 55:173–81

Alraek T, Fagerheim U, Baerheim A. Acupuncture treatment in theprevention of uncomplicated recurrent lower urinary tract infections inadult women. Am J Public Health 2002; 92:1609–11

Baerheim A, Larsen E, Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent urinary tract infection in women. Scand J Prim Health Care 1994;12:239–43.

Beerepoot MA, Geerlings SE, van Haarst EP, et al. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol 2013; 190:1981–9

Raz R. Urinary tract infections in postmenopausal women. In:Naber KGS, Heyns CF, Matsumoto T, Shoskes DA, Bjerklund Johansen TE, editors. Urogenital Infections. Arnhem, The Netherlands: European Association of Urology; 2010. p. 225–34

Albert X, Huertas I, Pereiró II, et al. Antibiotics for preventing recurrent urinary tract infection in non-pregnantwomen. Cochrane Database Syst Rev 2004;(3):CD001209.

Stapleton A, Stamm WE. Prevention of urinary tract infection. Infect Dis ClinNorth Am 1997; 11:719–33

L’Agence franc¸ aise de se´ curite´ sanitaire des produits de sante´ (afssaps). Nitrofurantoı¨ne et risque´ de survenue d’effets inde´ sirables he´patiques et pulmonaires lors de traitements prolonge´ s. Pharmacovigilance 2011. Infectiologie Web site. http://www.infectiologie.com/site/medias/_documents/consensus/lp-110311-%20nitrofurantoine.pdf

Cai T, Mazzoli S, Mondaini N, et al The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat? Clin Infect Dis 2012;55:771–7.